Top

Published in:

01-02-2010 | Review

Axillary reverse mapping for breast cancer

Author: Masakuni Noguchi

Published in: Breast Cancer Research and Treatment | Issue 3/2010

Abstract

The axillary reverse mapping (ARM) technique has been developed to map and preserve arm lymphatic drainage during axillary lymph node dissection (ALND) and/or sentinel lymph node (SLN) biopsy, thereby minimizing arm lymphedema. However, several problems remain to be resolved in the practical application of this technique. This article presents a review of current knowledge regarding ARM and discusses the practical applicability and relevance of this technique. Identification rates of ARM nodes were insufficient using blue dye. Although this was improved using radioisotopes, radioisotopes alone do not permit visual mapping of ARM lymphatics. Fluorescence imaging may be useful to improve the identification rate of ARM nodes and lymphatics. On the other hand, the ARM nodes may be involved with metastatic foci in patients with extensive axillary lymph node metastases. Moreover, the SLN draining the breast may be the same as the ARM node draining the upper extremity in a minority of patients. These issues represent important drawbacks of the ARM procedure. The success of ARM in reducing lymphedema has not yet been determined. Further studies are needed before this can be accepted as a standard procedure in surgical management of breast cancer.

Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614CrossRefPubMed

Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73:31–36CrossRefPubMed

Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM (2002) Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9:745–753CrossRefPubMed

Blanchard DK, Donohue JH, Reynolds C, Grant CS (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482–488CrossRefPubMed

Schijven MP, Vingerhoets AJJM, Rutten HJT, Nieuwenhuijzen GAP, Roumen RMH, van Bussel ME, Voogd AC (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29:341–350CrossRefPubMed

Ronka R, von Smitten K, Tasmuth T, Leidenius M (2005) One-year morbidity after sentinel node biopsy and breast surgery. Breast 14:28–36CrossRefPubMed

Leidenius M, Leivonen M, Vironen J, von Smitten K (2005) The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 92:23–31CrossRefPubMed

Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. JNCI 98:599–609PubMed

Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SGA, Lucci A, Cox CE, Hunt KK, Herndon JE II, Giuliano AE (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13:491–500CrossRefPubMed

10.

Sakorafas GH, Peros G, Cataliotti L, Vlastos G (2006) Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15:153–165CrossRefPubMed

11.

Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, Kimberg VS (2007) Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 14:1890–1895CrossRefPubMed

12.

Nos C, Leiseur B, Clough KB, Lecuru F (2007) Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol 14:2490–2496CrossRefPubMed

13.

Nos C, Kaufmann G, Clough KB, Collignon M-A, Zerbib E, Cusumano P, Lecuru F (2008) Combined axillary mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 15:2550–2555CrossRefPubMed

14.

Britton TB, Solanki CK, Pinder SE, Mortimer PS, Peters AM, Purushotham AD (2009) Lymphatic drainage pathways of the breast and the upper limb. Nucl Med Commun 30:427–430CrossRefPubMed

15.

Noguchi M, Miwa K, Michigishi T, Yokoyama K, Nishijima H, Takanaka T, Kawashima H, Nakamura S, Kanno H, Nonomura A (1997) The role of axillary lymph node dissection in breast cancer management. Breast Cancer 4:143–153CrossRefPubMed

16.

Siegel BM, Mayzel KA, Love SM (1990) Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 125:1144–1147PubMed

17.

Schunemann H, Willich N (1997) Lymphedema after breast carcinoma. A study of 5868 cases. Dtsch Med Wochenschr 122:536–541CrossRefPubMed

18.

Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, Klimberg VS (2008) Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 206:1038–1044CrossRefPubMed

19.

Klimberg VS (2008) A new concept toward the prevention of lymphedema: axillary reverse mapping. J Surg Oncol 97:563–564CrossRefPubMed

20.

Sappey MPC (1874) Anatomie, Physiologie, Pathologie des vaisseaux Lymphatiques consideres chez L’homme at les Vertebres. A. Delahaye and E. Lecrosnier, Paris

21.

Turner-Warwick RT (1959) The lymphatics of the breast. Br J Surg 46:574–582CrossRefPubMed

22.

Noguchi M, Inokuchi M, Zen Y (2009) Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy. J Surg Oncol 100:100–105CrossRefPubMed

23.

Suami H, Taylor GI, Pan W-R (2007) The lymphatic territories of the upper limb: anatomical study and clinical implications. Plast Reconstr Surg 119:1813–1822CrossRefPubMed

24.

Suami H, Pan W-R, Taylor GI (2007) Changes in the lymph structure of the upper limb after axillary dissection: radiographic and anatomical study in a human cadaver. Plast Reconstr Surg 120:982–991CrossRefPubMed

25.

Ponzone R, Mininanni P, Cassina E, Sismondi P (2008) Axillary reverse mapping in breast cancer: can we spare what we find? Ann Surg Oncol 15:390–391CrossRefPubMed

26.

Casabona F, Bogliolo S, Ferrero S, Boccardo F, Campisi C (2008) Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol 15:3318–3319CrossRefPubMed

27.

Casabona F, Bogliolo S, Valenzano Menada M, Sala P, Villa G, Ferrero S (2009) Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol 16:2459–2463CrossRefPubMed

28.

Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS (1996) Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. J Am Med Assoc 276:1818–1822CrossRef

29.

Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, Ohta M, Kurosumi M, Tsugawa K (2000) A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63:31–40CrossRefPubMed

30.

Noguchi M (2009) Axillary reverse mapping for preventing lymphedema in the axillary lymph node dissection and/or sentinel lymph node biopsy. Breast Cancer. doi:10.1007/s12282-009-0173-1

31.

Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with idocyanine fluorescent imaging in patients with breast cancer. J Surg Oncol (submitted)

32.

Celebioglu F, Perbeck L, Frisell J, Grondal E, Svensson L, Danielsson R (2007) Lymph drainage studied by lymphoscintigraphy in the arms after sentinel node biopsy compared with axillary lymph node dissection following conservative breast cancer surgery. Acta Radiol 48:488–495CrossRefPubMed

33.

Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663CrossRefPubMed

34.

McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5313–5319CrossRef

35.

Suami H, O’Neill JK, Pan W-R, Taylor GI (2008) Superficial lymphatic system of the upper torso: preliminary radiographic results in human cadavers. Plast Reconstr Surg 121:1231–1239CrossRefPubMed

36.

Sener SF, Winchester DJ, Martz CH, Feldman JL, Cavanaugh JA, Winchester DP, Weigel B, Bonnefoi K, Kirby K, Morehead C (2001) Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92:748–752CrossRefPubMed

37.

Campisi C, Eretta C, Pertile D, Rin ED, Campisi C, Maccio A, Campisi M, Accogli S, Bellini C, Boniolo E, Boccardo F (2007) Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives. Microsurgery 27:333–338CrossRefPubMed

38.

Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW Jr, Whelan TJ, Pfister DG et al (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1539–1569PubMed

39.

Noguchi M (2002) Does regional treatment improve the survival in patients with operable breast cancer? Breast Cancer Res Treat 76:269–282CrossRefPubMed

40.

Hiraoka M, Mitsumori M, Shibuya K (2002) Adjuvant radiation therapy following mastectomy for breast cancer. Breast Cancer 9:190–195CrossRefPubMed

Title: Axillary reverse mapping for breast cancer
Author: Masakuni Noguchi
Publication date: 01-02-2010
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 3/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-009-0578-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2010

Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial)

Treatment-related symptoms among underserved women with breast cancer: the impact of physician–patient communication

NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics

Loco-regional treatment in metastatic breast cancer patients: Is there a survival benefit?

Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance

Women’s decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid

Keynote webinar | Spotlight on antibody–drug conjugates in cancer